European Archives - Page 154 of 1507 - European Medical Journal

Universal Nirsevimab Cuts Infant RSV Hospitalisations - EMJ

Universal Nirsevimab Cuts Infant RSV Hospitalisations

Universal infant nirsevimab prophylaxis significantly reduced RSV-related hospitalisations and outpatient visits across two seasons in Spain.

Alcohol-related liver disease burden remains high - EMJ

Alcohol-Related Liver Disease Burden Remains High Despite Falling Consumption

New data show that alcohol-related liver disease continues to drive liver mortality, even where overall alcohol consumption has declined.

23 Jan 2026

Targeting Endothelin and Angiotensin in IgA Nephropathy

Endothelin-1 (ET-1) and angiotensin II (Ang II) overexpression is recognised as a mediator of disease progression in immunoglobulin…

$Stem Cell Eye Drops Show Early Promise in Refractory Dry Eye$

Stem Cell Eye Drops Improve Refractory Sjögren’s Dry Eye

A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and inflammation in refractory dry eye, including Sjögren’s syndrome.

Gestational Diabetes Tied to Widespread PFAS Chemicals

A major review links PFAS exposure to higher gestational diabetes risk, highlighting environmental chemicals as emerging pregnancy health concerns.

The world

Major philanthropies launch $60m AMR consortium

This first-of-its-kind global consortium aims to accelerate the discovery of treatments for the world’s most resistant pathogens.

New Asthma Drug Shows Promise in First Human Study

Londamocitinib produced approximately 50% reductions in fractional exhaled nitric oxide at the 1.4 mg and 3 mg doses.

Chiropractic Care

Chiropractic Care Influences Stress and Immune Biomarkers

Randomised trial shows chiropractic care alters stress, immune, and neuroplasticity biomarkers in adults with spinal pain.

Urine Output Predicts Mortality in Female ICU Patients

Early urine output patterns in female ICU patients with genitourinary infections are strongly linked to 28-day mortality and acute kidney injury risk.

Vagus Nerve Stimulation for Treatment-resistant Major Depression

Long-term trial data show vagus nerve stimulation sustains and even increases benefits for patients with severe treatment resistant depression.